Image of IMRAB Rabies Vaccine Vials

IMRAB® Rabies Vaccines

 

Veterinarians worldwide trust US market-leading IMRAB® vaccines for proven multi-species rabies protection.1

Image of IMRAB Rabies Vaccine Vials

IMRAB® Rabies Vaccines

 

Veterinarians worldwide trust US market-leading IMRAB® vaccines for proven multi-species rabies protection.1

Image of RECOMBITEK Canine Vaccines

RECOMBITEK® Canine Vaccines

 

RECOMBITEK® vaccines are highly purified, making them a safe and effective option to help protect your canine patients from dangerous diseases.

 

Image of RECOMBITEK Canine Vaccines

RECOMBITEK® Canine Vaccines

 

RECOMBITEK® vaccines are highly purified, making them a safe and effective option to help protect your canine patients from dangerous diseases.

 

Image of PUREVAX Feline Vaccines

PUREVAX® Feline Vaccines

 

Adjuvants can present potential risks to feline patients.2,3,4 PUREVAX® feline vaccines have been designed to elicit a protective immune response without the addition of adjuvants.

 

Image of PUREVAX Feline Vaccines

PUREVAX® Feline Vaccines

 

Adjuvants can present potential risks to feline patients.2,3,4 PUREVAX® feline vaccines have been designed to elicit a protective immune response without the addition of adjuvants.

 

Image of IMRAB Rabies Vaccine Vials

IMRAB® Rabies Vaccines

 

Veterinarians worldwide trust US market-leading IMRAB® vaccines for proven multi-species rabies protection.1

Image of IMRAB Rabies Vaccine Vials

IMRAB® Rabies Vaccines

 

Veterinarians worldwide trust US market-leading IMRAB® vaccines for proven multi-species rabies protection.1

Image of RECOMBITEK Canine Vaccines

RECOMBITEK® Canine Vaccines

 

RECOMBITEK® vaccines are highly purified, making them a safe and effective option to help protect your canine patients from dangerous diseases.

 

Image of RECOMBITEK Canine Vaccines

RECOMBITEK® Canine Vaccines

 

RECOMBITEK® vaccines are highly purified, making them a safe and effective option to help protect your canine patients from dangerous diseases.

 

Image of PUREVAX Feline Vaccines

PUREVAX® Feline Vaccines

 

Adjuvants can present potential risks to feline patients.2,3,4 PUREVAX® feline vaccines have been designed to elicit a protective immune response without the addition of adjuvants.

 

Image of PUREVAX Feline Vaccines

PUREVAX® Feline Vaccines

 

Adjuvants can present potential risks to feline patients.2,3,4 PUREVAX® feline vaccines have been designed to elicit a protective immune response without the addition of adjuvants.

 

Satisfaction Guarantee

Our commitment starts with science and technology to help you protect your patients and continues with support for you and your clients. We provide support in the event of a suspected adverse event (AE) or perceived lack of efficacy (LOE) associated with our vaccines and will provide reimbursement for any unused, expired doses, even if the vaccine tray has been opened.

A vet holds a dog's face in her hands

Our Commitment to Advancement

Like any good success story, ours started 35 years ago with a problem to solve. It was during those early days when our integrated approach began. By listening to the challenges veterinarians were facing and working collaboratively, we were able to develop what would become the US market-leading rabies vaccine—IMRAB®.1

IMRAB rabies vaccines were just the beginning. That commitment to helping protect your canine and feline patients from disease resulted in the development of additional breakthrough vaccine solutions—PUREVAX® vaccines for cats and RECOMBITEK® vaccines for dogs.

Listen. Innovate. Solve. We are committed to helping you protect patients from dangerous and deadly diseases as well as deepen the emotional bond pets share with their owners.

Our Commitment to Advancement

Like any good success story, ours started 35 years ago with a problem to solve. It was during those early days when our integrated approach began. By listening to the challenges veterinarians were facing and working collaboratively, we were able to develop what would become the US market-leading rabies vaccine—IMRAB®.1

IMRAB rabies vaccines were just the beginning. That commitment to helping protect your canine and feline patients from disease resulted in the development of additional breakthrough vaccine solutions—PUREVAX® vaccines for cats and RECOMBITEK® vaccines for dogs.

Listen. Innovate. Solve. We are committed to helping you protect patients from dangerous and deadly diseases as well as deepen the emotional bond pets share with their owners.

A vet holds a dog's face in her hands
Image showing 48,000 IMRAB vaccines given, 48,000 Recombitek vaccines given, and 3,300 PureVax vaccines given

Working for the Greater Good

Boehringer Ingelheim proudly works with organizations around the world to help prevent rabies through the Shots for Good program. Learn more about this lifesaving effort.

 

Reducing the Spread

See how Boehringer Ingelheim is providing vaccines to thousands of free-roaming dogs and cats to help stop the spread of diseases.

Care Where It’s Needed

Greater Good Charities® has been able to administer hundreds of vaccines across tribal reservations in New Mexico and Alaska.

More Work to Be Done

Focusing on states with large populations of free-roaming dogs, the goal is to vaccinate and provide access to veterinary care for 48,000 dogs and 3,300 cats.

 

 

 

Working for the Greater Good

Boehringer Ingelheim proudly works with organizations around the world to help prevent rabies through the Shots for Good program. Learn more about this lifesaving effort.

 

Reducing the Spread

See how Boehringer Ingelheim is providing vaccines to thousands of free-roaming dogs and cats to help stop the spread of diseases.

Care Where It’s Needed

Greater Good Charities® has been able to administer hundreds of vaccines across tribal reservations in New Mexico and Alaska.

More Work to Be Done

Focusing on states with large populations of free-roaming dogs, the goal is to vaccinate and provide access to veterinary care for 48,000 dogs and 3,300 cats.

 

 

 

Image showing 48,000 IMRAB vaccines given, 48,000 Recombitek vaccines given, and 3,300 PureVax vaccines given

Continuing Education

Image
Placard for the Boehringer Ingelheim Vaccine Continuing Education Series

Boehringer Ingelheim is here to support you and your staff with a wide variety of continuing education. Click the button to sign in or create an account to access free online educational courses.

Immunology & Vaccination

Become familiar with key players in the innate and adaptive immune system. Explore how vaccines influence the immune system and review the different types of commercially available vaccines for pets.

 

Rabies

This course recognizes the relevance of rabies today and the global impact vaccination has had on the disease, as Dr. Richard Ford (DVM, MS, DACVIM, DACVPM) discusses and clarifies vaccination laws for pets in different states.

 

Canine Infectious Respiratory Disease Complex (CIRDC)

Review the different risk factors for CIRDC and the diagnostic tests used to identify the implicated pathogens. Understand the importance mucosal immunity plays in helping prevent disease, and the varieties and methods of administration of available vaccines for dogs.

 

Sign Up for
BI-CONNECT™

Image
Image of the BI-Connect Desktop View

Manage your online orders, connect with our customer care team, and unlock CE courses approved by the Registry of Approved Continuing Education (RACE) program.

Free CE Courses

Earn CE credits from anywhere, for free, with our easy-to-access CE modules.

 

Simple Purchasing

Make purchases, manage product inventory, and see promotions in one convenient place.

 

Vet Professional Trainings

Access trainings and educational resources for your clinic.

 

References

1. Data on file at Boehringer Ingelheim.

 

2. Greene CE, Schultz RD. Immunoprophylaxis. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. 4th ed. St Louis, MO: Elsevier Saunders; 2012:1166-1169.

 

3. McNeil MM, DeStefano F. Vaccine-associated hypersensitivity. J Allergy Clin Immunol. 2018;141(2):463-472.

 

4. Day MJ, Schoon H-A, Magnol J-P, et al. A kinetic study of histopathological changes in the subcutis of cats injected with non-adjuvanted and adjuvanted multi-component vaccines. Vaccine. 2007; 25:4073-4084.

 

 

Trademarks

RECOMBITEK® and IMRAB® are registered trademarks, BI-CONNECT™ is a trademark, and SHOTS FOR GOODSM is a service mark of Boehringer Ingelheim Animal Health USA Inc. PUREVAX® is a registered trademark of Boehringer Ingelheim Animal Health France, used under license. All other trademarks are the property of their respective owner. ©2023 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All rights reserved.

US-PET-0025-2023-A

Order Now

Log in to your BI-CONNECT™ account or create a new account to place an order.